SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION ARTICLE M impact

European Commission Approves Obicetrapib Drugs Ubeslo and Evlarco

The European Commission granted the first worldwide regulatory approval of obicetrapib. Menarini plans launches in Germany by year-end 2026 and the UK in 2027; NewAmsterdam expects PREVAIL interim results in 1Q2027.

NAMS
SquawkNews Desk

The European Commission approved Ubeslo and Evlarco, the first worldwide regulatory approval of obicetrapib. Menarini plans launches in Germany by year-end 2026 and the UK in 2027; NewAmsterdam expects PREVAIL interim results in 1Q2027.Material DetailsContext by AI AnalystThis is a commercial trans…

Related stories

UK Minister Asks CMA and Ofcom to Report on ITV-Sky Deal by Jan. 27 Culture Minister Nandy says she has asked the CMA and Ofcom to report back by 27 January on the ITV-Sky deal. L impact | REGULATION | Nov 04, 2026, 01:14 PM UTC Jiangsu Leili Motor Controller Su Da Placed Under Regulatory Investigation L impact | REGULATION | Nov 04, 2026, 01:02 PM UTC Switzerland Agrees to Pay Medical Bills for Italian Fire Victims Switzerland agreed to cover medical bills for Italian victims of the Crans Montana fire. L impact | REGULATION | Nov 04, 2026, 12:54 PM UTC South Korea Special Counsel Bill Clears Judiciary Committee The bill passed South Korea’s Legislation and Judiciary Committee. The Democratic Party is pushing for it to be handled at a plenary session on the 5th. L impact | REGULATION | Nov 04, 2026, 12:43 PM UTC NewAmsterdam Pharma Q3 Net Loss Narrows 76% to USD 17.39 Million The company reported a net loss of USD 17.39 million for Q3 2026, down 76% year over year. M impact | EQUITY | Nov 04, 2026, 12:38 PM UTC Spain’s Transport Minister Resigns After Rail Crashes Kill More Than 100 Spain’s transport minister resigned after two railway accidents that left more than 100 people dead. H impact | REGULATION | Nov 04, 2026, 12:34 PM UTC